Cite
HARVARD Citation
Idzerda, N. et al. (2018). N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk. Diabetes, obesity & metabolism. 20 (12), pp. 2899-2904. [Online].